Ownership history in Legacy CG, LLC Β· 3 quarters on record
This page tracks every 13F SEC filing in which Legacy CG, LLC reported a position in ABBVIE INC (ABBV). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Legacy CG, LLC outperformed the S&P 500 by +28.9% annually on this ABBV position. Average cost basis: $205.22. Maximum drawdown during holding period: β0.6%.
π₯ Exceptional β beat the S&P 500 by 28.9% per year on this position.
2 quarters analyzed
Best entry: $181.25 (2025 Q2) Β· Worst: $228.05 (2025 Q3)
π No drawdown exceeding 20% during the holding period β exceptionally stable.
2 adds Β· 1 trim. Bought during 0 of 1 down-price quarters. π More buys than sells across the holding period.
π Legacy CG, LLC has been actively increasing its ABBV allocation β a bullish signal from insiders.
Currently 1.77% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size